150 research outputs found

    Challenges, teachers and gifted learners in mathematics

    Get PDF
    In this paper we reflect on the nature of the mathematical challenges and their important role in the care of students with mathematically talented students, and we insist on the possible roles that teachers can play. We stress the need for the math teacher achieve a specialized knowledge on formulating appropriate mathematical challenges, in order to identify and to encourage mathematically talented students in the classroom. We exemplify these ideas with specific challenges, showing teacher strategies used to formulate mathematical challenges around a specific content and how to sequence them.En este artículo reflexionamos sobre la naturaleza de los retos y de su importante papel en la atención de los estudiantes con talento matemático e incidimos en las posibles funciones que puede desempeñar el profesor. Destacamos la necesidad de que el profesor de matemáticas tenga un conocimiento especializado sobre la formulación de retos matemáticos apropiados para la identificación y el estímulo de los estudiantes con talento matemático en el aula. Ejemplificamos estas ideas con retos específicos, mostrando estrategias que puede utilizar el profesor para formular retos matemáticos en torno a un contenido específico y cómo organizar su secuencia didáctica en el aula

    What makes a task a problem in early childhood education?

    Get PDF
    This article begins with a theoretical discussion of the characteristics that a task should feature to be regarded as a mathematics problem suitable for pre-primary students. Those considerations are followed by a report of a classroom experience in which three problems involving quotative or partitive division were posed to pre-primary school pupils to determine the presence of otherwise of the respective characteristics. The findings show that the characteristics of pre-primary education problems depend on two factors: mathematical activity that engages pupils and a structure that favours both their understanding of the problem and the application and verification of the solutions

    Relationship of runoff, erosion and sediment yield to weather types in the Iberian Peninsula

    Get PDF
    Precipitation has been recognized as one of the main factors driving soil erosion and sediment yield (SY), and its spatial and temporal variability is recognized as one of themain reasons for spatial and temporal analyses of soil erosion variability. The weather types (WTs) approach classifies the continuumof atmospheric circulation into a small number of categories or types and has been proven a good indicator of the spatial and temporal variability of precipitation. Thus, themain objective of this study is to analyze the relationship betweenWTs, runoff, soil erosion (measured in plots), and sediment yield (measured in catchments) in different areas of the Iberian Peninsula (IP) with the aimof detecting spatial variations in these relationships. To this end, hydrological and sediment information covering the IP from several Spanish research teams has been combined, and related with daily WTs estimated by using the NMC/NCAR 40-Year Reanalysis Project. The results showthat, in general, a fewWTs (particularly westerly, southwesterly and cyclonic) provide the largest amounts of precipitation; and southwesterly, northwesterly and westerly WTs play an important role in runoff generation, erosion and sediment yield as they coincide with the wettest WTs. However, this study highlights the spatial variability of erosion and sediment yield in the IP according to WT, differentiating (1) areas under the influence of north and/or north-westerly flows (the north coast of Cantabria and inland central areas), (2) areas under the influence of westerly, southwesterly and cyclonic WTs (western and southwestern IP), (3) areas in which erosion and sediment yield are controlled by easterly flows (Mediterranean coastland), and (4) lastly, a transitional zone in the inland northeast Ebro catchment,wherewe detected a high variability in the effects ofWTs on erosion. Overall results suggest that the use of WTs derived fromobserved atmospheric pressure patterns could be a useful tool for inclusion in future projections of the spatial variability of erosion and sediment yield, as models capture pressure fields reliably

    Prognostic factors in left-sided endocarditis: results from the andalusian multicenter cohort

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Despite medical advances, mortality in infective endocarditis (IE) is still very high. Previous studies on prognosis in IE have observed conflicting results. The aim of this study was to identify predictors of in-hospital mortality in a large multicenter cohort of left-sided IE.</p> <p>Methods</p> <p>An observational multicenter study was conducted from January 1984 to December 2006 in seven hospitals in Andalusia, Spain. Seven hundred and five left-side IE patients were included. The main outcome measure was in-hospital mortality. Several prognostic factors were analysed by univariate tests and then by multilogistic regression model.</p> <p>Results</p> <p>The overall mortality was 29.5% (25.5% from 1984 to 1995 and 31.9% from 1996 to 2006; Odds Ratio 1.25; 95% Confidence Interval: 0.97-1.60; p = 0.07). In univariate analysis, age, comorbidity, especially chronic liver disease, prosthetic valve, virulent microorganism such as <it>Staphylococcus aureus</it>, <it>Streptococcus agalactiae </it>and fungi, and complications (septic shock, severe heart failure, renal insufficiency, neurologic manifestations and perivalvular extension) were related with higher mortality. Independent factors for mortality in multivariate analysis were: Charlson comorbidity score (OR: 1.2; 95% CI: 1.1-1.3), prosthetic endocarditis (OR: 1.9; CI: 1.2-3.1), <it>Staphylococcus aureus </it>aetiology (OR: 2.1; CI: 1.3-3.5), severe heart failure (OR: 5.4; CI: 3.3-8.8), neurologic manifestations (OR: 1.9; CI: 1.2-2.9), septic shock (OR: 4.2; CI: 2.3-7.7), perivalvular extension (OR: 2.4; CI: 1.3-4.5) and acute renal failure (OR: 1.69; CI: 1.0-2.6). Conversely, <it>Streptococcus viridans </it>group etiology (OR: 0.4; CI: 0.2-0.7) and surgical treatment (OR: 0.5; CI: 0.3-0.8) were protective factors.</p> <p>Conclusions</p> <p>Several characteristics of left-sided endocarditis enable selection of a patient group at higher risk of mortality. This group may benefit from more specialised attention in referral centers and should help to identify those patients who might benefit from more aggressive diagnostic and/or therapeutic procedures.</p

    A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

    Get PDF
    Meeting abstrac

    Author Correction:A consensus protocol for functional connectivity analysis in the rat brain

    Get PDF

    Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Get PDF
    Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p&lt;0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (&lt;1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (&lt;1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

    The European Solar Telescope

    Get PDF
    The European Solar Telescope (EST) is a project aimed at studying the magnetic connectivity of the solar atmosphere, from the deep photosphere to the upper chromosphere. Its design combines the knowledge and expertise gathered by the European solar physics community during the construction and operation of state-of-the-art solar telescopes operating in visible and near-infrared wavelengths: the Swedish 1m Solar Telescope, the German Vacuum Tower Telescope and GREGOR, the French Télescope Héliographique pour l’Étude du Magnétisme et des Instabilités Solaires, and the Dutch Open Telescope. With its 4.2 m primary mirror and an open configuration, EST will become the most powerful European ground-based facility to study the Sun in the coming decades in the visible and near-infrared bands. EST uses the most innovative technological advances: the first adaptive secondary mirror ever used in a solar telescope, a complex multi-conjugate adaptive optics with deformable mirrors that form part of the optical design in a natural way, a polarimetrically compensated telescope design that eliminates the complex temporal variation and wavelength dependence of the telescope Mueller matrix, and an instrument suite containing several (etalon-based) tunable imaging spectropolarimeters and several integral field unit spectropolarimeters. This publication summarises some fundamental science questions that can be addressed with the telescope, together with a complete description of its major subsystems
    corecore